Literature DB >> 25833351

Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.

Kazuhiro Kitajima1, Yuko Suenaga, Yoshiko Ueno, Tetsuo Maeda, Yasuhiko Ebina, Hideto Yamada, Takashi Okunaga, Kazuhiro Kubo, Keitarou Sofue, Tomonori Kanda, Yukihisa Tamaki, Kazuro Sugimura.   

Abstract

PURPOSE: To evaluate the usefulness of metabolic parameters obtained by (18)F-FDG PET/CT for preoperative stratification of high-risk and low-risk endometrial carcinomas.
METHODS: Preoperative (18)F-FDG PET/CT was performed in 56 women with endometrial cancer. Maximum standardized uptake values (SUVmax), metabolic tumour volume (MTV) and total lesion glycolysis (TLG) of primary tumours were compared with clinicopathological features of surgical specimens. Diagnostic performance in terms of differentiation of low-risk disease (endometrioid histology, histological grade 1 or 2, invasion of less than half of the myometrium, and FIGO stage I) from high-risk disease was assessed.
RESULTS: MTV and TLG were significantly higher in patients with higher histological grade (p = 0.0026 and p = 0.034), larger tumour size (p = 0.002 and p = 0.0017), lymphovascular space involvement (LVSI; p = 0.012 and p = 0.0051), myometrial invasion (p = 0.027 and p = 0.031), cervical stromal invasion (p = 0.023 and p = 0.014), ovarian metastasis (p = 0.00022 and p = 0.00034), lymph node metastasis (p < 0.0001 and p < 0.0001), and higher FIGO stage (p = 0.0011 and p = 0.00048). SUVmax was significantly higher in patients with larger tumour size (p = 0.0025), LVSI (p = 0.00023) and myometrial invasion (p < 0.0001). The areas under the ROC curves (AUCs) for distinguishing high-risk from low-risk carcinoma were 0.625, 0.829 and 0.797 for SUVmax, MTV and TLG, respectively. AUCs for both MTV and TLG were significantly larger than that for SUVmax (p = 0.0049 and p = 0.021). The optimal TLG cut-off value of 70.2, determined by ROC analysis, was found to have 72.0% sensitivity and 74.2% specificity for risk stratification.
CONCLUSION: MTV and TLG of primary endometrial cancer show better correlations with clinicopathological features and are more useful for differentiating high-risk from low-risk carcinoma than SUVmax.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833351     DOI: 10.1007/s00259-015-3037-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  24 in total

1.  Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.

Authors:  Kazuhiro Kitajima; Masato Kita; Kayo Suzuki; Michio Senda; Yuji Nakamoto; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-17       Impact factor: 9.236

Review 2.  Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology.

Authors:  John A Lee
Journal:  Radiother Oncol       Date:  2010-08-11       Impact factor: 6.280

Review 3.  Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis.

Authors:  Kyoungjune Pak; Gi Jeong Cheon; Hyun-Yeol Nam; Seong-Jang Kim; Keon Wook Kang; June-Key Chung; E Edmund Kim; Dong Soo Lee
Journal:  J Nucl Med       Date:  2014-04-21       Impact factor: 10.057

4.  Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.

Authors:  H J Lee; B-C Ahn; C M Hong; B I Song; H W Kim; S Kang; S Y Jeong; S-W Lee; J Lee
Journal:  Nuklearmedizin       Date:  2011-07-05       Impact factor: 1.379

5.  Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.

Authors:  S-H Shim; D-Y Kim; D-Y Lee; S-W Lee; J-Y Park; J J Lee; J-H Kim; Y-M Kim; Y-T Kim; J-H Nam
Journal:  BJOG       Date:  2014-01-08       Impact factor: 6.531

6.  FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer.

Authors:  Tatsuo Torizuka; Fumitoshi Nakamura; Munetaka Takekuma; Toshihiko Kanno; Tomomi Ogusu; Etsuji Yoshikawa; Hiroyuki Okada; Makoto Maeda; Yasuomi Ouchi
Journal:  Nucl Med Commun       Date:  2006-06       Impact factor: 1.690

Review 7.  Current issues in the management of endometrial cancer.

Authors:  Jamie N Bakkum-Gamez; Jesus Gonzalez-Bosquet; Nadia N Laack; Andrea Mariani; Sean C Dowdy
Journal:  Mayo Clin Proc       Date:  2008-01       Impact factor: 7.616

8.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

Review 9.  Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis.

Authors:  Haleh Ghooshkhanei; Giorgio Treglia; Golnaz Sabouri; Rozita Davoodi; Ramin Sadeghi
Journal:  Gynecol Oncol       Date:  2014-01-25       Impact factor: 5.482

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  18 in total

1.  Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.

Authors:  Tomomi Nobashi; Sho Koyasu; Yuji Nakamoto; Takeshi Kubo; Takayoshi Ishimori; Young H Kim; Akihiko Yoshizawa; Kaori Togashi
Journal:  Br J Radiol       Date:  2016-01-12       Impact factor: 3.039

2.  Role of Positron Emission Tomography/Computed Tomography in Preoperative Assessment of Carcinoma Endometrium-a Retrospective Analysis.

Authors:  Rohini Kulkarni; Rani Akhil Bhat; Vibhawari Dhakharia; Kumar Kallur; Aparna Gangoli
Journal:  Indian J Surg Oncol       Date:  2018-11-20

3.  Primary tumor SUVmax on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy.

Authors:  Shigetaka Yagi; Tamaki Yahata; Yasushi Mabuchi; Yuko Tanizaki; Aya Kobayashi; Michihisa Shiro; Nami Ota; Sawako Minami; Masaki Terada; Kazuhiko Ino
Journal:  Mol Clin Oncol       Date:  2016-07-07

4.  Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.

Authors:  Hyun Hoon Chung; Gi Jeong Cheon; Jae-Weon Kim; Noh-Hyun Park; Yong Sang Song
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-21       Impact factor: 9.236

5.  Verification of the tumor volume delineation method using a fixed threshold of peak standardized uptake value.

Authors:  Kazuya Koyama; Takuya Mitsumoto; Takahiro Shiraishi; Keisuke Tsuda; Atsushi Nishiyama; Kazumasa Inoue; Kyosan Yoshikawa; Kazuo Hatano; Kazuo Kubota; Masahiro Fukushi
Journal:  Radiol Phys Technol       Date:  2017-07-04

6.  Prognostic impact of primary tumor SUVmax on preoperative 18F-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography in endometrial cancer and uterine carcinosarcoma.

Authors:  Tamaki Yahata; Shigetaka Yagi; Yasushi Mabuchi; Yuko Tanizaki; Aya Kobayashi; Madoka Yamamoto; Mika Mizoguchi; Sakiko Nanjo; Michihisa Shiro; Nami Ota; Sawako Minami; Masaki Terada; Kazuhiko Ino
Journal:  Mol Clin Oncol       Date:  2016-08-04

7.  18F-FDG PET/CT can predict chemosensitivity and proliferation of epithelial ovarian cancer via SUVmax value.

Authors:  Shuai Liu; Zheng Feng; Hao Wen; Zhaoxia Jiang; Herong Pan; Yu Deng; Lei Zhang; Xingzhu Ju; Xiaojun Chen; Xiaohua Wu
Journal:  Jpn J Radiol       Date:  2018-06-25       Impact factor: 2.374

Review 8.  What Is the Best Preoperative Imaging for Endometrial Cancer?

Authors:  Ingfrid S Haldorsen; Helga B Salvesen
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

9.  18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients.

Authors:  Lu Bai; Chihua Guo; Jiansheng Wang; Xiang Liu; Yang Li; Miao Li; Youmin Guo; Xiaoyi Duan
Journal:  Onco Targets Ther       Date:  2016-10-14       Impact factor: 4.147

10.  Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer.

Authors:  Seo Young Kang; Gi Jeong Cheon; Maria Lee; Hee Seung Kim; Jae-Weon Kim; Noh-Hyun Park; Yong Sang Song; Hyun Hoon Chung
Journal:  Transl Oncol       Date:  2017-02-03       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.